Infusion therapy for cerebral infarction is about two weeks, the main purpose is to protect the nerves, improve blood circulation, protect the mitochondria, improve the signs and symptoms of neurological deficits, at the same time, lowering the cranial pressure and waking up the brain treatment.1, neuroprotective therapy drugs, mainly edaravone, cytidine diphosphate, protein hydrolysate and piracetam, mainly for the treatment of cellular damage after acute ischemia or reperfusion, which can protect the brain cells and It can protect brain cells and improve tolerance to ischemia and hypoxia.2. Cranial pressure lowering treatment is mainly applied to those with cerebral edema and increased intracranial pressure, seen in large cerebral infarction, the patients’ cerebral edema and increased intracranial pressure began to appear on the second day after the onset of the disease, began to reduce after one week, and gradually returned to normal in two weeks, so the treatment of cranial pressure lowering is in the two weeks of the onset of the disease.3. In addition, the treatment of butylphthalide is mainly used to improve signs and symptoms of neurological deficits. It is applicable within two weeks of the onset of the disease. At the same time, it can also improve the blood circulation treatment, mainly applying Panax ginseng, safflower, ginkgo biloba preparation, and blood-sparing and Vibramycin, etc., which is also used within two weeks of the onset of the disease.